REGULATION OF SUBSTANCE-P RELEASE MEDIATED VIA PREJUNCTIONAL HISTAMINE H-3 RECEPTORS

被引:70
作者
OHKUBO, T
SHIBATA, M
INOUE, M
KAYA, H
TAKAHASHI, H
机构
[1] Department of Pharmacology, Fukuoka Dental College, Sawaraku, Fukuoka, 814-01
[2] Endodontics and Periodontics, Fukuoka Dental College, Sawara-ku, Fukuoka, 814-01
关键词
SUBSTANCE P; HISTAMINE H-3 RECEPTOR; NEUROGENIC INFLAMMATION;
D O I
10.1016/0014-2999(94)00668-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The involvement of the histamine H-3 receptor in the regulation of substance P release in neurogenic inflammation was studied by using rat hindpaw skin. R-(-)-alpha-Methylhistamine, a specific histamine H-3 receptor agonist, significantly inhibited the increased vascular permeability induced by antidromic electrical stimulation of the sciatic nerve in a dose-dependent manner at doses of 0.5-3 mg/kg (i.v.), and thioperamide (2 mg/kg i.p.), a specific histamine H-3 receptor antagonist, prevented the inhibitory effect of R-(-)-alpha-methylhistamine. The antidromic stimulation also caused a significant increase in immunoreactive substance P release in the subcutaneous (s.c.) perfusate in the rat hindpaw. R-(-)-alpha-Methylhistamine (0.25-2 mg/kg) dose dependently inhibited the increase in release of immunoreactive substance P, and thioperamide (2 mg/mg i.p.) antagonized it. Perfusion of histamine (10(-3) M) elicited a significant increase of immunoreactive substance P release in the perfusate, which was reduced by R-(-)-alpha-methylhistamine and the antagonism of thioperamide was also observed. Histamine (in the presence of histamine H-1 and H-2 receptor antagonists) had an inhibitory effect on the electrically evoked release of immunoreactive substance P. These results strongly support the hypothesis that histamine regulates substance P release via prejunctional histamine H-3 receptors that are located on peripheral endings of sensory nerves.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 23 条
[1]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[2]   AUTOINHIBITION OF HISTAMINE SYNTHESIS MEDIATED BY PRESYNAPTIC H-3 RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1987, 23 (01) :149-157
[3]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[4]   MODULATION OF NEUROGENIC INFLAMMATION - NOVEL APPROACHES TO INFLAMMATORY DISEASE [J].
BARNES, PJ ;
BELVISI, MG ;
ROGERS, DF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (05) :185-189
[5]  
BELVISI MG, 1989, BRIT J PHARMACOL, V97, P1125
[6]   AGONISTS AT MU-OPIOID, M-2-MUSCARINIC AND GABAB-RECEPTORS INCREASE THE SAME POTASSIUM CONDUCTANCE IN RAT LATERAL PARABRACHIAL NEURONS [J].
CHRISTIE, MJ ;
NORTH, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :896-902
[7]  
FINK K, 1990, N-S ARCH PHARMACOL, V342, P513
[8]  
FROSSARD N, 1987, EUR J PHARMACOL, V142, P519
[9]   DECREASE OF SUBSTANCE-P IN PRIMARY AFFERENT NEURONS AND IMPAIRMENT OF NEUROGENIC PLASMA EXTRAVASATION BY CAPSAICIN [J].
GAMSE, R ;
HOLZER, P ;
LEMBECK, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 68 (02) :207-213
[10]   EVIDENCE THAT SUBSTANCE-P IS A MEDIATOR OF ANTIDROMIC VASODILATATION USING SOMATOSTATIN AS A RELEASE INHIBITOR [J].
GAZELIUS, B ;
BRODIN, E ;
OLGART, L ;
PANOPOULOS, P .
ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 113 (02) :155-159